NIH Scientists Develop Blood Test to Help Improve Liver Cancer Screening
A specific viral exposure signature that could accurately distinguish people with HCC from those with chronic liver disease and healthy volunteers.
Read MorePosted by Laurie Bonner | Jun 12, 2020 | Uncategorized |
A specific viral exposure signature that could accurately distinguish people with HCC from those with chronic liver disease and healthy volunteers.
Read MorePosted by Laurie Bonner | Jun 9, 2020 | Covid 19 |
The kit enables isolation of viral RNA from swab specimens that are dry or in VTM, reducing the shortage of RNA purification kits used in covid-19 testing.
Read MorePosted by Steve Halasey | Jun 9, 2020 | Uncategorized |
The company will use a new technology to develop a blood test for the detection of early-stage cancer.
Read MorePosted by Laurie Bonner | Jun 4, 2020 | Clinical Chemistry Test Kits, Dementias & Alzheimer’s |
Research suggests the biomarker could be critical to predicting Alzheimer’s disease progression and differentiating the disease from other disorders.
Read MorePosted by Laurie Bonner | Jun 2, 2020 | Covid 19 |
The guidelines address the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2.
Read More